[HTML][HTML] Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance, and urinary chromium loss in obese mice
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin… - Veterinary …, 2021 - mdpi.com
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice
GR Chang, PH Hou, CM Wang, JW Lin… - Veterinary …, 2021 - pubmed.ncbi.nlm.nih.gov
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
[PDF][PDF] Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese …
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin, TC Lin… - 2021 - pdfs.semanticscholar.org
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
[HTML][HTML] Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese …
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin… - Veterinary …, 2021 - ncbi.nlm.nih.gov
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin, TC Lin… - agris.fao.org
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance, and urinary chromium loss in obese mice.
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin, TC Lin… - 2021 - cabidigitallibrary.org
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice.
GR Chang, PH Hou, CM Wang, JW Lin, WL Lin… - Veterinary …, 2021 - europepmc.org
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice
GR Chang, PH Hou, W Chao-Min… - Veterinary …, 2021 - search.proquest.com
Imipramine is a tricyclic antidepressant that has been approved for treating depression and
anxiety in patients and animals and that has relatively mild side effects. However, the …
anxiety in patients and animals and that has relatively mild side effects. However, the …